Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: Harold Engstrom who wrote (3658)	11/30/2002 11:08:53 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 10345

a manufacturing facility that could be subsidized by Ligand..... etc., etc. dunno..... I believe that the delivery/formulations business has been way undervalued among the prognosticators. If I'm correct and SEC doesn't kill the company, then I feel that they can turn the corner with assets that make the current MC look small. JVs..... a few of them could hit the big time. If ELN turns the corner, it will be healthy IMO, with out without antegren. frovo..... the triptan market is so under-penetrated, it's silly. but there's little competitive advantage to frovo. it needs to be marketed like crazy, as patients who try (and like) a given triptan will be unlikely IMO to test further waters. One thing is likely, IMO..... a couple of triptans will go on to command a billion. patient experiences and word of mouth will be the determining factor. my satisfaction with rizatriptan has already led to many, many new customers for Merck. but, as satisfied as I am, I almost always take a repeat dose within 24 hours due to headache recurrence. reality check...... antegren..... forget the BS at Yahoo. it's not a gimme. I'm also excited. Anyone who isn't a shareholder is, IMO, not a traditional biotech investor at heart. However, I've still got only my modest position, and I'm not raising the bet until I figure out why the shorts are so confident. Given that short interest has now stabilized and that there are some very stupid shorts in the stock, maybe I should say "were" instead of "are"? I hope so. I would love to see both the shorts and the naysayers stuff this one up their collective rear. If one looks at the variety of projects that have derived from Athena, I feel that anyone working against this company is just plain rotten in the soul department.